Davita Inc vs Target Corporation — how do they compare? Davita Inc trades at $178.89 (market cap $11.29B), while Target Corporation trades at $153.73 (market cap $70.31B). The key difference: Target Corporation is far larger — about 6.2× Davita Inc's market cap, and Target Corporation pays a 3% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Target Corporation for 137 Days on average.
| DVA | TGT | |
|---|---|---|
Market Cap | $11.29B | $70.31B |
Volume | 582,204 | 4,164,999 |
Sector | Health | Consumer Staples |
52-Week High | $240.96 | $169.90 |
52-Week Low | $103.87 | $83.68 |
Typical Hold Time | 113 Days | 137 Days |
Enterprise Value | $24.01B | $83.58B |
Dividend Yield | — | 3% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
Target trades at $150.96, down 2.18% today, with technical indicators showing bearish momentum. The company maintains solid fundamentals with a P/E of 16.05 and strong profitability metrics including 26.41% ROE. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $4.11 significantly exceeding the $2.35 forecast. The company's holiday price-cutting strategy aims to capture market share amid competitive retail pressures.
Target presents a mixed outlook with 46.7% analyst buy ratings and a $167.18 consensus target suggesting 10.8% upside. Strong cash flow generation and dividend sustainability support the investment case, though margin pressures from aggressive pricing and retail competition pose near-term challenges. The stock's current valuation appears reasonable relative to historical levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →